Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany: II. The contribution of leflunomide to efficiency.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples